Clinical Trial Update: Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Octohydroaminoacridine succinate tablets in mild-to-moderate Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Octohydroaminoacridine succinate tablet (octohydroaminoacridine succinate)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Alzheimer Disease | Phase 3 | Status: UNKNOWN